GSI 1 (Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)

Generic Name: cobicistat/elvitegravir/emtricitabine/tenofovir

Pill imprint GSI 1 has been identified as Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg.

Stribild is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GSI 1

Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg GSI 1
Stribild cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg GSI 1
Stribild
Generic Name:
cobicistat/elvitegravir/emtricitabine/tenofovir
Imprint:
GSI
1
Strength:
cobicistat 150 mg/elvitegravir 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg
Color:
Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gilead Sciences, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)